GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » EV-to-FCF

Medlive Technology Co (HKSE:02192) EV-to-FCF : 17.79 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medlive Technology Co's Enterprise Value is HK$1,349.6 Mil. Medlive Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$75.8 Mil. Therefore, Medlive Technology Co's EV-to-FCF for today is 17.79.

The historical rank and industry rank for Medlive Technology Co's EV-to-FCF or its related term are showing as below:

HKSE:02192' s EV-to-FCF Range Over the Past 10 Years
Min: -12.93   Med: 22.6   Max: 242.02
Current: 18.44

During the past 6 years, the highest EV-to-FCF of Medlive Technology Co was 242.02. The lowest was -12.93. And the median was 22.60.

HKSE:02192's EV-to-FCF is ranked better than
51.61% of 62 companies
in the Medical Distribution industry
Industry Median: 20.635 vs HKSE:02192: 18.44

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Medlive Technology Co's stock price is HK$8.37. Medlive Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.360. Therefore, Medlive Technology Co's PE Ratio for today is 23.25.


Medlive Technology Co EV-to-FCF Historical Data

The historical data trend for Medlive Technology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co EV-to-FCF Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - 282.60 18.72 18.62

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only 282.60 - 18.72 - 18.62

Competitive Comparison of Medlive Technology Co's EV-to-FCF

For the Medical Distribution subindustry, Medlive Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's EV-to-FCF falls into.



Medlive Technology Co EV-to-FCF Calculation

Medlive Technology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1349.580/75.842
=17.79

Medlive Technology Co's current Enterprise Value is HK$1,349.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$75.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medlive Technology Co  (HKSE:02192) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medlive Technology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.37/0.360
=23.25

Medlive Technology Co's share price for today is HK$8.37.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.360.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medlive Technology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines